Ep. 22 - Oral GLP-1 Breakthroughs and the Future of Weight Loss

The Scalpel's Edge
18/11/2025 30 min
Ep. 22 - Oral GLP-1 Breakthroughs and the Future of Weight Loss

Listen "Ep. 22 - Oral GLP-1 Breakthroughs and the Future of Weight Loss"

Descargar episodio

Episode Synopsis

A new era of weight management is on the horizon. In this episode of The Scalpel’s Edge, learn how oral GLP-1 medications like semaglutide (Rebelsus) are changing the landscape of obesity care and cardiovascular health. Explore key findings from the OASIS-4 Phase 3 trial, new FDA updates, and what the data reveals about blood sugar control, heart health, and weight reduction across all age groups. Discover why oral options may soon rival injectables like Ozempic, Wegovy, and Mounjaro—and what this means for the millions of people seeking sustainable wellness solutions.Contact Dr. Tim Sayed:Phone: (858) 247-2933Email: [email protected]: timsayedmd.comInstagram: @timsayedmdYouTube: @TimsayedmdFacebook: Tim Sayed MD

More episodes of the podcast The Scalpel's Edge

Ep. 24 - How Genetic Testing Supports Explant Surgery and Holistic Healing 16/12/2025
Ep. 23 - Why Twenty Four Celebrities Chose Breast Implant Removal 02/12/2025
Ep. 21 - Clinical Outcomes After Explant Surgery for Breast Implant Illness 04/11/2025
Ep. 20 - The Rise of Explant Surgery and the Power of Body Autonomy 21/10/2025
Ep. 19 - FDA Warnings, Compounded GLP1s, and the Next Generation of Weight Loss Medications 07/10/2025
Ep. 18 - GLP1 Medications Heart Health and Environmental Impact 09/09/2025
Ep. 17 - Breast Implant Illness: What the Data Reveals 26/08/2025
Ep. 16 - Reset the Clock Not the Hormones 12/08/2025
Ep. 15 - GLP1 Breakthroughs and Real Results 29/07/2025
Ep. 14 - Inside the SHARP Program: A Doctor’s Journey Through Detox and Recovery 15/07/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA